About Covis

At Covis, our paramount concern is patients’ outcomes as we focus on improving the health of people with serious medical conditions.

Covis is always evaluating products and corporate acquisition opportunities. Covis is well-capitalized and has significant resources committed from its equity sponsors for tack-on deals and larger transaction opportunities.

 

Click here to access our California Compliance Statement and Declaration.

18  Brands in the current portfolio

Sold in  50+  countries

Long-term supply agreements with  10+  manufacturers ensuring supply chain security

Values

The ethos at Covis Pharma is focused on five key pillars:

Collaboration

With all stakeholders ensuring access to their ‘best in class’ products for all patients, including those in most need

Diversification

Firm believers in corporate diversity

Development

Focusing on developing and extending therapeutic solutions for patients and physicians globally, and professional growth for employees and partners

Entrepreneurial

Striving to create new opportunities that deliver results for all stakeholders

Integrity

Strong governance and compliance, to ensure ethical behaviour in all interactions and work they do

Team

Partnerships

We partner with the world’s leading pharmaceutical companies and contract manufacturing organizations to deliver an uninterrupted supply of high-quality pharmaceuticals.

Operational Capabilities

Covis has unparalleled expertise across all functional areas with a flawless history of executing commercial onboarding, tech transferring, and launching authorized generic and line extension products.

Business Development

Covis is always evaluating products and corporate acquisition opportunities with significant resources committed from its equity sponsors for tack-on deals and larger transaction opportunities. For all partnering inquiries, please contact us.

Product Development

Covis is devoted to developing new therapeutic solutions to improve patients’ quality of life through line extensions of its existing portfolio as well as selected novel late-stage clinical programs.

Our Operating Partners

Our Business Development Partners

Our Authorized Distributors of Record

Asia-Pacific

Europe

United States

Brazil and Mexico

South Africa

The product information on this website is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.
© Copyright 2017-2021 Covis Pharma. All rights reserved.

Skip to content